In addition, mutations in CTDSP2, APC, KRAS, TP53 and NFKBIZ were suggestively associated with CRT resistance because KRAS and TP53 are known colorectal cancer driver genes and key players in preoperative CRT resistance 45-50. This evidence concerns the gene KRAS and colorectal cancer.